These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23143962)

  • 1. [Genetic bases of attention deficit hyperactivity disorder].
    Sanchez-Mora C; Ribases M; Mulas F; Soutullo C; Sans A; Pamias M; Casas M; Ramos-Quiroga JA
    Rev Neurol; 2012 Nov; 55(10):609-18. PubMed ID: 23143962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate gene studies of attention-deficit/hyperactivity disorder.
    Faraone SV; Khan SA
    J Clin Psychiatry; 2006; 67 Suppl 8():13-20. PubMed ID: 16961425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
    Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF
    Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.
    Bonvicini C; Faraone SV; Scassellati C
    Mol Psychiatry; 2016 Jul; 21(7):872-84. PubMed ID: 27217152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of DAT1 and COMT variants on neural activation during response inhibition in adolescents with attention-deficit/hyperactivity disorder and healthy controls.
    van Rooij D; Hoekstra PJ; Bralten J; Hakobjan M; Oosterlaan J; Franke B; Rommelse N; Buitelaar JK; Hartman CA
    Psychol Med; 2015 Nov; 45(15):3159-70. PubMed ID: 26073896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine risk and paternal ADHD symptomatology associated with ADHD symptoms in four and a half-year-old boys.
    Auerbach JG; Atzaba-Poria N; Berger A; Landau R; Arbelle S; Raz Y; Ebstein R
    Psychiatr Genet; 2010 Aug; 20(4):160-5. PubMed ID: 20421851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What do dopamine transporter and catechol-o-methyltransferase tell us about attention deficit-hyperactivity disorder? Pharmacogenomic implications.
    Levy F
    Aust N Z J Psychiatry; 2007 Jan; 41(1):10-6. PubMed ID: 17464676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizotypy, attention deficit hyperactivity disorder, and dopamine genes.
    Ettinger U; Joober R; DE Guzman R; O'driscoll GA
    Psychiatry Clin Neurosci; 2006 Dec; 60(6):764-7. PubMed ID: 17109713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk of attention deficit/hyperactivity disorder in Aymara and Rapa-Nui school children: association with dopaminergic system polymorphisms].
    Paz Lagos L; Silva C; Rothhammer P; Carrasco X; Llop E; Aboitiz F; Rothhammer F
    Rev Med Chil; 2011 May; 139(5):600-5. PubMed ID: 22051710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the attention deficit hyperactivity disorder (ADHD) phenotype: sustained attention, response variability and spatial attentional asymmetries in relation to dopamine transporter (DAT1) genotype.
    Bellgrove MA; Hawi Z; Kirley A; Gill M; Robertson IH
    Neuropsychologia; 2005; 43(13):1847-57. PubMed ID: 16168728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding genes, environment and their interaction in attention-deficit hyperactivity disorder: is there a role for neuroimaging?
    Plomp E; Van Engeland H; Durston S
    Neuroscience; 2009 Nov; 164(1):230-40. PubMed ID: 19619618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of an association of a promoter polymorphism of the dopamine transporter gene and Attention Deficit Hyperactivity Disorder.
    Doyle C; Brookes K; Simpson J; Park J; Scott S; Coghill DR; Hawi Z; Kirley A; Gill M; Kent L
    Neurosci Lett; 2009 Sep; 462(2):179-81. PubMed ID: 19576958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic background of ADHD: population studies, genes of the catecholamine system].
    Słopién A; Dmitrzak-Weglarz M; Rybakowski F; Rajewski A; Hauser J
    Psychiatr Pol; 2006; 40(1):19-31. PubMed ID: 16756025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile].
    Henríquez B H; Henríquez H M; Carrasco Ch X; Rothhammer A P; Llop R E; Aboitiz F; Rothhammer E F
    Rev Med Chil; 2008 Jun; 136(6):719-24. PubMed ID: 18769827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.
    Kustanovich V; Ishii J; Crawford L; Yang M; McGough JJ; McCracken JT; Smalley SL; Nelson SF
    Mol Psychiatry; 2004 Jul; 9(7):711-7. PubMed ID: 14699430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate system analysis in ADHD: evaluation of nine genes involved in dopaminergic neurotransmission identifies association with DRD1.
    Ribasés M; Ramos-Quiroga JA; Hervás A; Sánchez-Mora C; Bosch R; Bielsa A; Gastaminza X; Lesch KP; Reif A; Renner TJ; Romanos M; Warnke A; Walitza S; Freitag C; Meyer J; Palmason H; Casas M; Bayés M; Cormand B
    World J Biol Psychiatry; 2012 Apr; 13(4):281-92. PubMed ID: 22404661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6-10 age.
    Kopecková M; Paclt I; Petrásek J; Pacltová D; Malíková M; Zagatová V
    Neuro Endocrinol Lett; 2008 Apr; 29(2):246-51. PubMed ID: 18404133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relations between multi-informant assessments of ADHD symptoms, DAT1, and DRD4.
    Gizer IR; Waldman ID; Abramowitz A; Barr CL; Feng Y; Wigg KG; Misener VL; Rowe DC
    J Abnorm Psychol; 2008 Nov; 117(4):869-80. PubMed ID: 19025233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genomic endophenotypes of attention deficit hyperactivity disorder].
    Fernández-Jaén A; Fernández-Mayoralas DM; Calleja-Pérez B; Muñoz-Jareño N; López-Arribas S
    Rev Neurol; 2012 Feb; 54 Suppl 1():S81-7. PubMed ID: 22374776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the dopamine transporter gene and the inattentive subtype of attention deficit hyperactivity disorder in Taiwan.
    Shang CY; Gau SS; Liu CM; Hwu HG
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):421-8. PubMed ID: 20800641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.